文献速递乳腺乳腺X线US

848例乳腺病灶术前射频标签定位的回顾性分析

Retrospective Review of Preoperative Radiofrequency Tag Localization of Breast Lesions in 848 Patients.
PubMed 文献 · AJR Am J Roentgenol · 2020-10-21

该回顾性研究纳入2018年7月12日至2019年7月31日连续848例术前接受影像引导射频标签定位的乳腺病灶患者,共置入1013枚标签,技术准确率99.1%,成功率达98.4%,所有847例手术患者标签均成功取出,作者认为该技术安全可行,可作为针/导丝定位的替代选择。

要点

  • 射频标签定位技术准确率99.1%(1004/1013),成功率达98.4%(997/1013)。
  • 9枚定位不准确标签中7枚(77.8%)需额外放置标签或导丝。
  • 7枚(0.7%)活检夹标记物在置入过程中移位或被标签装置带出。

核心结论

  • 术前影像引导射频标签定位对于需手术的乳腺病灶是一种安全可行的技术。
  • 射频标签定位是可接受的针或导丝定位替代方案,可能改善患者工作流程和体验。

研究设计与样本

  • 回顾性研究,纳入2018年7月12日至2019年7月31日连续接受影像引导针定位后手术切除的患者848例,共置入1013枚射频标签,847例后续接受手术切除。
  • 评估指标包括标签放置的病理诊断指征、影像引导方式、放置标签数量、目标病灶类型、技术准确率(定义为标签展开在目标边缘1 cm以内)、成功率(定义为无并发症的技术准确)以及手术切缘和再切除状态。

诊断标准与关键数值

  • 技术准确率定义为标签展开在目标病灶边缘1 cm以内,共1004枚(99.1%)标签达到技术准确。
  • 成功率定义为无并发症的技术准确,共997枚(98.4%)标签达到成功。
  • 标签最常用于浸润性癌(537/1013,53.0%)、导管原位癌(138/1013,13.6%)和高危病变(289/1013,28.5%)。
  • 673枚(66.4%)标签在乳腺X线引导下置入,340枚(33.6%)在超声引导下置入。
  • 目标病灶类型主要为肿块(448/1013,44.2%)、活检夹标记物(331/1013,32.7%)和钙化(155/1013,15.3%)。

临床应用与阅片要点

  • 848例患者中149例(17.6%)放置了2枚或以上标签。
  • 9枚标签放置不准确,其中7枚(77.8%)需额外放置标签或导丝。
  • 7枚(0.7%)活检夹标记物在乳腺内移位或在放置过程中被标签装置移除。
  • 术中未报告并发症,847例手术患者中所有标签均成功取出。
  • 568例术前诊断为癌的患者中,86例(15.1%)手术切缘阳性或接近阳性,需再次手术切除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Advantages of radiofrequency tags for preoperative breast lesion localization include decoupling of tag placement from surgical schedules and improved patient comfort. OBJECTIVE. The purpose of this study was to evaluate the feasibility of a preoperative localization radiofrequency tag system for breast lesions requiring surgical excision. METHODS. The cohort for this retrospective study included consecutive patients who underwent image-guided needle localization with radiofrequency tags before surgical excision from July 12, 2018, to July 31, 2019. Images and medical records were reviewed to evaluate the pathologic diagnoses serving as indications for tag placement, imaging guidance for tag placement, number of tags placed, and target lesion type. Tag placement technical accuracy rate (defined as deployment of the tag within 1 cm of the edge of the target), success (defined as technical accuracy without complication), and surgical margin and reexcision status were evaluated. RESULTS. A total of 1013 tags were placed under imaging guidance in 848 patients (mean age, 60 years; range, 23-96 years) and 847 subsequently underwent surgical excision. Tags were most commonly placed for invasive carcinoma (537/1013, 53.0%), ductal carcinoma in situ (138/1013, 13.6%), and high-risk lesions (289/1013, 28.5%). A total of 673 (66.4%) tags were deployed under mammographic guidance, whereas 340 (33.6%) were placed under sonographic guidance. Two or more tags were placed in 149 of 848 patients (17.6%). Targeted lesion types primarily included masses (448/1013, 44.2%), biopsy clip markers (331/1013, 32.7%), and calcifications (155/1013, 15.3%). Technical accuracy of placement was achieved in 1004 (99.1%) tags. Of the nine inaccurate tag placements, seven (77.8%) required an additional tag or wire placement. Seven (0.7%) biopsy clip markers were displaced within the breast or removed by the tag device during placement. No complications were reported intraoperatively. Therefore, success was achieved in 997 (98.4%) tags. Tags were successfully retrieved in all 847 patients who underwent surgery. Of the 568 patients with a preoperative diagnosis of carcinoma, 86 (15.1%) had positive or close surgical margins requiring surgical reexcision. CONCLUSION. Preoperative image-guided localization with radiofrequency tags is a safe and feasible technique for breast lesions requiring surgery. CLINICAL IMPACT. Radiofrequency tag localization is an acceptable alternative to needle or wire localization, offering the potential for improved patient workflow and experience.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lamb LR, Gilman L, Specht M, et al. Retrospective Review of Preoperative Radiofrequency Tag Localization of Breast Lesions in 848 Patients. AJR Am J Roentgenol. 2020. PMID: 33084384. doi:10.2214/AJR.20.24374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。